Desmopressin acutely decreases tachycardia and improves symptoms in the postural tachycardia syndrome.

doi:10.1016/j.hrthm.2012.05.002

Paper

DOI: 10.1016/j.hrthm.2012.05.002

Desmopressin acutely decreases tachycardia and improves symptoms in the postural tachycardia syndrome.

Published Sep 1, 2012 · S. Coffin, Bonnie K. Black, I. Biaggioni

Heart rhythm

Q1 SJR score

Citations

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

RCT

Highly Cited

Study Snapshot

Oral desmopressin significantly reduces tachycardia and improves symptoms in patients with postural tachycardia syndrome.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Sign up to use Study Snapshot

Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.

Create an account

Full text analysis coming soon...

References

DOI: 10.5664/JCSM.28110

Sleep disturbances and diminished quality of life in postural tachycardia syndrome.

Patients with postural tachycardia syndrome (POTS) experience more sleep problems, excessive daytime sleepiness, higher fatigue levels, and worse sleep and health-related quality of life compared to healthy control subjects.

2011·122citations·K. Bagai et al.·Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine

DOI: 10.1016/j.jacc.2010.02.043

Cardiac origins of the postural orthostatic tachycardia syndrome.

Exercise training improves postural orthostatic tachycardia syndrome (POTS) in most patients by increasing left ventricular mass and blood volume, suggesting a potential new name for the condition: "Grinch syndrome."

2010·192citations·Q. Fu et al.·Journal of the American College of Cardiology

Journal of the American College of Cardiology

DOI: 10.1161/CIRCULATIONAHA.108.846501

Propranolol Decreases Tachycardia and Improves Symptoms in the Postural Tachycardia Syndrome: Less Is More

Low-dose oral propranolol significantly reduces tachycardia and improves symptoms in postural tachycardia syndrome, while higher doses may not further improve and may worsen symptoms.

2009·185citations·S. Raj et al.·Circulation

Circulation

DOI: 10.1212/01.wnl.0000267663.05398.40

The hemodynamic and neurohumoral phenotype of postural tachycardia syndrome

Postural tachycardia syndrome (POTS) is associated with increased sympathetic activation and abnormalities in the renin-angiotensin-aldosterone system.

2007·147citations·E. Garland et al.·Neurology

Neurology

DOI: 10.1097/MAJ.0B013E318063C6C0

Blood volume perturbations in the postural tachycardia syndrome.

Postural tachycardia syndrome (POTS) is associated with low blood volume, and regulating blood volume may be crucial for managing symptoms and improving functional disability.

2007·65citations·S. Raj et al.·The American journal of the medical sciences

The American journal of the medical sciences

Citations

DOI: 10.1016/j.nurpra.2024.105258

Management of Postural Orthostatic Tachycardia Syndrome: A Canadian Approach

Canadian guidelines recommend nonpharmacological and pharmacological approaches for managing postural orthostatic tachycardia syndrome, with no approved pharmacological approaches in Canada.

2025·0citations·M. E. El Hussein et al.·The Journal for Nurse Practitioners

The Journal for Nurse Practitioners

DOI: 10.1016/j.cpcardiol.2024.102977

Pathophysiology and Management of Postural Orthostatic Tachycardia Syndrome (POTS): A Literature Review.

Lifestyle modifications and pharmacologic therapies are effective first-line treatments for POTS, with phenotype-based approaches guiding tailored treatment for hyperadrenergic, neuropathic, and hypovolemic phenotypes.

2024·0citations·Mohamad Ghazal et al.·Current problems in cardiology

Current problems in cardiology

DOI: 10.4103/neurol-india.ni_651_22

Postural Orthostatic Tachycardia Syndrome (POTS) as a Cause of Dizziness - Expanding the Etiological Spectrum.

POTS should be considered a possible cause of orthostatic dizziness in patients without orthostatic fall in blood pressure, with anxiety and headache potentially associated.

2024·0citations·Dipti Baskar et al.·Neurology India

Neurology India

DOI: 10.3390/medicina60081325

Postural Orthostatic Tachycardia Syndrome Associated with COVID-19: A Narrative Review

COVID-19-related postural orthostatic tachycardia syndrome (POTS) can cause fatigue, difficulty standing, tachycardia, and cognitive challenges, and requires holistic treatment approaches.

2024·0citations·Jung-Hyun Park et al.·Medicina

Medicina

DOI: 10.3390/jpm14040435

Autoimmunity in Syndromes of Orthostatic Intolerance: An Updated Review

Autoimmunity is associated with orthostatic intolerance, and immunomodulation therapy may improve autonomic symptoms in POTS and OH.

2024·4citations·Clarissa Pena et al.·Journal of Personalized Medicine

Journal of Personalized Medicine